CANDIDO, SAVERIO
 Distribuzione geografica
Continente #
NA - Nord America 4.799
EU - Europa 2.792
AS - Asia 2.221
SA - Sud America 454
AF - Africa 302
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.574
Nazione #
US - Stati Uniti d'America 4.662
SG - Singapore 1.183
RU - Federazione Russa 936
IT - Italia 826
CN - Cina 636
BR - Brasile 402
IE - Irlanda 383
CI - Costa d'Avorio 215
UA - Ucraina 198
DE - Germania 158
VN - Vietnam 146
CA - Canada 105
GB - Regno Unito 46
IN - India 46
FI - Finlandia 43
KR - Corea 40
SE - Svezia 39
SN - Senegal 36
BD - Bangladesh 27
NL - Olanda 27
FR - Francia 26
MX - Messico 25
PL - Polonia 23
AR - Argentina 22
TR - Turchia 22
ZA - Sudafrica 20
CH - Svizzera 17
ES - Italia 16
IQ - Iraq 16
JP - Giappone 16
AT - Austria 14
HK - Hong Kong 14
ID - Indonesia 12
IR - Iran 12
UZ - Uzbekistan 10
NG - Nigeria 8
PK - Pakistan 8
CO - Colombia 7
VE - Venezuela 7
NP - Nepal 6
BE - Belgio 5
BG - Bulgaria 5
BJ - Benin 5
GR - Grecia 5
LT - Lituania 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
KE - Kenya 4
KZ - Kazakistan 4
RO - Romania 4
TN - Tunisia 4
AU - Australia 3
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CM - Camerun 2
CZ - Repubblica Ceca 2
IL - Israele 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
JO - Giordania 1
KI - Kiribati 1
LI - Liechtenstein 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.574
Città #
Dallas 1.148
Singapore 681
Santa Clara 663
Chandler 420
Moscow 406
Dublin 375
Jacksonville 278
Catania 233
Chicago 219
Abidjan 215
Ashburn 157
Boardman 151
Beijing 124
Los Angeles 103
Cambridge 100
Lawrence 100
Hefei 94
Andover 91
Grafing 84
Nanjing 82
Toronto 73
Houston 65
Des Moines 55
Wilmington 52
Dong Ket 47
New York 46
Civitanova Marche 43
Palermo 42
Seoul 38
Dakar 36
Ho Chi Minh City 34
São Paulo 34
Columbus 30
Council Bluffs 30
San Mateo 30
Buffalo 29
Hanoi 29
The Dalles 28
Hebei 27
Nanchang 25
Rome 25
Helsinki 23
Saint Petersburg 22
Orem 19
Shenyang 19
Warsaw 19
Messina 18
Jiaxing 16
Tokyo 15
Falls Church 14
Hong Kong 14
Lappeenranta 14
Acireale 13
Bremen 13
Guangzhou 13
Johannesburg 13
Naples 13
Rio de Janeiro 13
San Jose 13
Belo Horizonte 12
Dearborn 12
Mexico City 12
Padova 12
Amsterdam 11
Milan 11
Ottawa 11
Brooklyn 10
Frankfurt am Main 10
Munich 10
Phoenix 10
Augusta 9
Baghdad 9
Curitiba 9
London 9
Montreal 9
Nuremberg 9
Redwood City 9
Tianjin 9
Abuja 8
Aci Catena 8
Ankara 8
Boston 8
Chennai 8
Jinan 8
Mascalucia 8
Mumbai 8
Norwalk 8
Poplar 8
Stockholm 8
Changsha 7
Denver 7
Florence 7
Kochi 7
Leawood 7
San Francisco 7
Seattle 7
Den Haag 6
Frankfurt Am Main 6
Porto Alegre 6
Redmond 6
Totale 7.180
Nome #
Gut Microbiota and Cancer: From Pathogenesis to Therapy 246
Advances in targeting signal transduction pathways. 224
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain 176
Computational modelling in melanoma for novel drug discovery 163
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 162
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 158
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 155
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 153
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 153
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 144
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 144
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 143
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker 140
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 139
Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer 138
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 132
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 131
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 129
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 129
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 129
Prognostic significance of deregulated microRNAs in uveal melanomas 128
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 124
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 124
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 123
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 122
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 122
Cutaneous melanoma: From pathogenesis to therapy 121
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review) 119
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 118
Nitric Oxide in Hematological Cancers: Partner or Rival? 115
Analisi delle mutazioni Rac1 nei lavoratori con melanoma cutaneo esposti al sole per motivi professionali 112
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 112
Analysis of PIK3CA mutations in cutaneous melanoma patients with occupational sun exposure 111
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 111
Pericytes in microvessels: From “mural” function to brain and retina regeneration 111
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 111
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 110
Emerging targeted therapies for melanoma treatment (review) 109
Dysregulation of IL-6 cis- and trans-signaling and high frequency of IL6R rs2228145(C>A) in the management of Deep Vein Thrombosis 107
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 107
microRNAs and thyroid cancer: Biological and clinical significance (Review). 103
Role of microRNAs as novel diagnostic biomarkers and potential therapeutic targets for hearing disorders (Review) 101
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 100
Environment and bladder cancer: Molecular analysis by interaction networks 100
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study 96
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA 95
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma 94
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets 91
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer 91
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 90
Cancer therapy and treatments during COVID-19 era 89
Cutaneous melanoma and the immunotherapy revolution (Review) 87
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment 87
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance 86
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 85
Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 84
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity 83
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells 79
Functions of NGAL and GSK-3beta in sensitivity to targeted, chemo- and hormonal-based therapies 76
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. 76
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 75
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 75
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey 75
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 75
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis 75
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship 75
MMP-9 is a candidate marker of response to treatment with dabrafenib in melanoma cells 74
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells 73
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells 73
Direct oral anticoagulant treatment of deep vein thrombosis reduces IL‑6 expression in peripheral mono‑nuclear blood cells 72
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. 72
Overexpression of Sthamin-1 in lung cancer from patients exposed to asbestos: an "in silico" evaluation 71
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 70
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 70
Targeting signaling pathways involved in metastasis in cancer stem cells 69
Interaction between matrix metalloproteinase-9 (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL): A recent evolutionary event in primates 69
Suppressing prostate cancer by targeting NGAL 68
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial 67
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals 67
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 66
Detection of B-Rat mutations in ovarian cancer is associated with chemoresistance 65
Neopterin: a potential marker in chronic peripheral arterial disease 65
Metformin influences drug sensitivity in pancreatic cancer cells 65
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 64
Overexpression of nectin like-5 is associated with a malignant phenotype in cutaneous melanoma 64
The tumor microenvironment in hepatocellular carcinoma 63
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells 62
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder 62
Overexpression of Sthamin-1 is associated with the development of lung cancer developed in patients exposed to asbestos 62
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression 61
Implication of IL-6 in the development of HCV-associated non-Hodgkin lymphoma 61
V600E B-Raf mutation is associated with chemoresistance in ovarian cancer 61
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines 61
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer 60
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 60
YY1 silencing induces 5-fluorouracil-resistance and BCL2L15 downregulation in colorectal cancer cells: Diagnostic and prognostic relevance 60
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. 58
Interactions between immune and environmental stimuli in non-Hodgkin Lymphoma 58
Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer 58
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53 58
Totale 9.857
Categoria #
all - tutte 36.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021411 0 0 0 0 0 33 75 0 109 15 121 58
2021/2022727 62 107 5 33 102 15 100 25 52 23 21 182
2022/20231.326 114 69 30 144 118 201 11 208 321 25 56 29
2023/2024540 20 80 32 27 24 100 25 34 11 20 93 74
2024/20252.652 24 390 143 142 589 286 131 103 210 266 176 192
2025/20264.149 328 511 1.073 394 786 1.057 0 0 0 0 0 0
Totale 10.765